Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

VISTA checkpoint inhibition by pH-selective antibody SNS-101 with optimized safety and pharmacokinetic profiles enhances PD-1 response
Thomas Thisted, F. Donelson Smith, Arnab Mukherjee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 11

Showing 11 citing articles:

VISTA-induced tumor suppression by a four amino acid intracellular motif
Yan Zhao, T Andoh, Fatima Charles, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access | Times Cited: 1
Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer Immunotherapy
Zhihao Qi, Yao Cheng, Kaizhen Wang, et al.
Journal of Medicinal Chemistry (2025)
Closed Access | Times Cited: 1
Chidamide functions as a VISTA/PSGL-1 blocker for cancer immunotherapy
Xiaoshuang Niu, Wenshan Zhao, Xiuman Zhou, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 3
Open Access
PD-1H (VISTA) expression in cutaneous squamous cell carcinoma is correlated with T cell infiltration and activation
Michal Kidacki, Christina Cho, Francesc López‐Giráldez, et al.
Journal of Investigative Dermatology (2025)
Closed Access
Immune Checkpoint Blockade Therapies for Colorectal Cancer: Current Strategies and Emerging Approaches
Kelly Pum, Christopher J. LaRocca, Paolo Goffredo, et al.
JCO oncology advances. (2025), Iss. 2
Closed Access
VISTA as a context-dependent immune checkpoint: Implications for tumor immunity and autoimmune pathogenesis
Xiaoshuang Niu, Beibei Li, Feng Luo, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 3, pp. 189351-189351
Closed Access
The bispecific antibody targeting VISTA and PD-L1 shows enhanced tumor inhibitory activity in pancreatic, endometrial and breast cancers compared to mono- and combination immune checkpoint blockade
Przemysław Bielski, Jan Barczyński, Michał Mikitiuk, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A pair of promising immune checkpoints PSGL-1 and VISTA from immunotolerance to immunotherapy
Manqing Peng, Xiaofang Lu, Junshuang Guo, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
Targeting of immune checkpoint regulator V-domain Ig suppressor of T-cell activation (VISTA) with 89Zr-labelled CI-8993
Ingrid J.G. Burvenich, Christian Wichmann, Alexander Franklin McDonald, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 13, pp. 3863-3873
Open Access | Times Cited: 1
Humanized Mouse Models of Bacterial Infections
Katya McDonald, Adryiana Rodriguez, Gowrishankar Muthukrishnan
Antibiotics (2024) Vol. 13, Iss. 7, pp. 640-640
Open Access
The Diverse Roles of the Tumour Microenvironment in Carcinogenesis
Ismail Ibrahim Al-Janabi
Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) (2024) Vol. 7, Iss. 2, pp. 26-37
Open Access
Page 1

Scroll to top